Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey
Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Summary
The purpose of this study is to assess adherence, tolerability and satisfaction of each eligible HIV subjects switching from a two- or three-pill tenofovir-emtricitabine-efavirenz (TDF-FTC-EFV) to a one-pill TDF-FTC-EFV treatment.
Official title: HIV-positive Patients Under Tenofovir, Emtricitabine and Efavirenz Therapy Switching From a Two-pill Regimen to a Single Pill Regimen: Patients'Opinion Survey
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
95
Start Date
2010-07
Completion Date
2012-02
Last Updated
2026-07-17
Healthy Volunteers
No
Conditions
Locations (1)
Centre Hospitalier Universitaire Vaudois et Policlinique Medicale Universitaire
Lausanne, Canton of Vaud, Switzerland